Better Together, Improved Solutions for Rare diseases

Dipharma is a Swiss pharmaceutical company which provides high-quality drugs with improved properties such as an enhanced stability, to those who suffer from congenital metabolic disorders. Dipharma is pioneering an agile pharmaceutical business model which anticipates changes and which is based on rigorous and at the same time fluid processes.
Everyday top priority is taking care of people: patients, partners, employees.
Dipharma continuously listens to patients, parents, patient associations and physicians to learn about their needs and work on identifying sustainable solutions together.